B. V. Robinson

511 total citations
19 papers, 300 citations indexed

About

B. V. Robinson is a scholar working on Molecular Biology, Aquatic Science and Pharmacology. According to data from OpenAlex, B. V. Robinson has authored 19 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Aquatic Science and 4 papers in Pharmacology. Recurrent topics in B. V. Robinson's work include Seaweed-derived Bioactive Compounds (4 papers), Natural product bioactivities and synthesis (3 papers) and Phytochemistry and Bioactive Compounds (2 papers). B. V. Robinson is often cited by papers focused on Seaweed-derived Bioactive Compounds (4 papers), Natural product bioactivities and synthesis (3 papers) and Phytochemistry and Bioactive Compounds (2 papers). B. V. Robinson collaborates with scholars based in United Kingdom, Tanzania and Canada. B. V. Robinson's co-authors include M. E. J. Billingham, J. M. Robson, Niall S. Doherty, Joseph F. Borzelleca, J. M. Robson, Frank Sullivan, Sorell L. Schwartz, A. H. Gordon, P. A. Revell and J. M. Gaugas and has published in prestigious journals such as Nature, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

B. V. Robinson

18 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. V. Robinson United Kingdom 12 94 56 48 46 35 19 300
Haeng Soon Park South Korea 8 118 1.3× 23 0.4× 26 0.5× 52 1.1× 84 2.4× 15 335
Jichao Cao China 12 128 1.4× 45 0.8× 33 0.7× 37 0.8× 35 1.0× 19 422
Hong‐Jen Liang Taiwan 11 109 1.2× 64 1.1× 25 0.5× 83 1.8× 29 0.8× 14 382
Mahmood Khaniki Iran 9 166 1.8× 28 0.5× 18 0.4× 35 0.8× 40 1.1× 16 364
Fengyuan Chen China 12 227 2.4× 58 1.0× 28 0.6× 69 1.5× 36 1.0× 16 520
L. Hegemann Austria 10 91 1.0× 47 0.8× 27 0.6× 63 1.4× 20 0.6× 15 346
Jong-Gwan Kim South Korea 8 146 1.6× 19 0.3× 12 0.3× 74 1.6× 73 2.1× 14 368
Susan Hawthorne United Kingdom 15 237 2.5× 28 0.5× 44 0.9× 41 0.9× 76 2.2× 27 611
William M. Mackin United States 9 124 1.3× 48 0.9× 10 0.2× 78 1.7× 7 0.2× 16 359
No-June Park South Korea 14 116 1.2× 15 0.3× 56 1.2× 48 1.0× 18 0.5× 30 398

Countries citing papers authored by B. V. Robinson

Since Specialization
Citations

This map shows the geographic impact of B. V. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. V. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. V. Robinson more than expected).

Fields of papers citing papers by B. V. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. V. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. V. Robinson. The network helps show where B. V. Robinson may publish in the future.

Co-authorship network of co-authors of B. V. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of B. V. Robinson. A scholar is included among the top collaborators of B. V. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. V. Robinson. B. V. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Robinson, B. V., Frank Sullivan, Joseph F. Borzelleca, & Sorell L. Schwartz. (2018). PVP. 44 indexed citations
2.
Keen, Eric C., et al.. (2012). Improving detection of extended-spectrum beta-lactamase-producing bacteria in a deployed setting.. PubMed. 70–3. 1 indexed citations
3.
Ings, R. M. J., Alan Gray, Florence Edwards‐Lévy, et al.. (1990). The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice. Cancer Chemotherapy and Pharmacology. 27(2). 106–110. 3 indexed citations
4.
Gibson, K. Michael, William L. Nyhan, K. Narisawa, et al.. (1985). 823 3-METHYLGLUTACONYL-CoA HYDRATASE DEFICIENCY: TWO DIFFERENT CLINICAL AND ENZYMATIC PHENOTYPES IN 3-METHYLGLUTACONIC ACIDURIA. Pediatric Research. 19(4). 248A–248A. 6 indexed citations
5.
Robinson, B. V.. (1982). Histamine receptor agonists and antagonists on granulocyte adherence. Journal of Pharmacy and Pharmacology. 34(7). 458–461. 6 indexed citations
6.
Robinson, B. V.. (1981). Antimicrobial Drug Action. Biochemical Society Transactions. 9(3). 258–259. 11 indexed citations
7.
Revell, P. A., et al.. (1979). Investigations of Harpagophytum procumbens (Devil's Claw) in the treatment of experimental inflammation and arthritis in the rat [proceedings].. PubMed. 66(1). 140P–141P. 15 indexed citations
8.
Robinson, B. V.. (1978). The Pharmacology of Phagocytosis. Lara D. Veeken. XVII(suppl). 37–46. 5 indexed citations
9.
Doherty, Niall S. & B. V. Robinson. (1977). Erythrocyte fragility during inflammation in the rat. Life Sciences. 20(8). 1383–1387. 1 indexed citations
10.
Doherty, Niall S. & B. V. Robinson. (1976). Lysosomal stabilization as the possible mechanism of action of an endogenous anti-inflammatory protein. Biochemical Pharmacology. 25(18). 2039–2044. 6 indexed citations
11.
Doherty, Niall S. & B. V. Robinson. (1976). Some biological and pharmacological properties of inflammatory exudates. Journal of Pharmacy and Pharmacology. 28(12). 859–864. 13 indexed citations
12.
Doherty, Niall S. & B. V. Robinson. (1975). The inflammatory response to carrageenan. Journal of Pharmacy and Pharmacology. 27(9). 701–703. 30 indexed citations
13.
Billingham, M. E. J. & B. V. Robinson. (1972). Separation of irritancy from the anti‐inflammatory component of inflammation exudate. British Journal of Pharmacology. 44(2). 317–320. 20 indexed citations
14.
Billingham, M. E. J., A. H. Gordon, & B. V. Robinson. (1971). Role of the Liver in Inflammation. Nature New Biology. 231(18). 26–27. 25 indexed citations
15.
Billingham, M. E. J., B. V. Robinson, & J. M. Gaugas. (1970). Two Anti-inflammatory Components in Antilymphocytic Serum. Nature. 227(5255). 276–277. 16 indexed citations
16.
Billingham, M. E. J., B. V. Robinson, & J. M. Robson. (1969). Anti-Inflammatory Properties of Human Inflammatory Exudate. BMJ. 2(5649). 93–96. 18 indexed citations
17.
Billingham, M. E. J., B. V. Robinson, & J. M. Robson. (1969). Partial purification of the anti‐inflammatory factor(s) in inflammatory exudate. British Journal of Pharmacology. 35(3). 543–557. 33 indexed citations
18.
Robinson, B. V. & J. M. Robson. (1966). FURTHER STUDIES ON THE ANTI‐INFLAMMATORY FACTOR FOUND AT A SITE OF INFLAMMATION. British Journal of Pharmacology and Chemotherapy. 26(2). 372–384. 23 indexed citations
19.
Robinson, B. V. & J. M. Robson. (1964). PRODUCTION OF AN ANTI‐INFLAMMATORY SUBSTANCE AT A SITE OF INFLAMMATION. British Journal of Pharmacology and Chemotherapy. 23(2). 420–432. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026